LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
This Quarter Return
-5.02%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$593M
AUM Growth
-$12M
(-2%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
3,071
New
350
Increased
1,339
Reduced
784
Closed
167
Top Buys
| 1 |
RPAR Risk Parity ETF
RPAR
|
$4.61M |
| 2 |
Golub Capital BDC
GBDC
|
$3.18M |
| 3 |
Oaktree Specialty Lending
OCSL
|
$2.74M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$2.52M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$2.23M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
$928K |
| 2 |
Vanguard Value ETF
VTV
|
$665K |
| 3 |
Kinder Morgan
KMI
|
$658K |
| 4 |
Nike
NKE
|
$596K |
| 5 |
Intercontinental Exchange
ICE
|
$519K |
Sector Composition
| 1 | Financials | 19.66% |
| 2 | Technology | 11.68% |
| 3 | Healthcare | 5.38% |
| 4 | Consumer Discretionary | 4.17% |
| 5 | Energy | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Boston Scientific
BSX
$159B
| $465K | 0.08% |
11,999
+321
| +3% | +$12.4K |
|
152
Novo Nordisk
NVO
$252B
| $465K | 0.08% |
9,344
+56
| +0.6% | +$2.79K |
|
|
ETRN
153
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $464K | 0.08% |
61,991
-5,293
| -8% | -$39.6K |
|
154
Thermo Fisher Scientific
TMO
$183B
| $462K | 0.08% |
911
+106
| +13% | +$53.8K |
|
155
Vanguard Mid-Cap Value ETF
VOE
$18.6B
| $457K | 0.08% |
3,750
-9
| -0.2% | -$1.1K |
|
156
DT Midstream
DTM
$10.6B
| $456K | 0.08% |
8,786
-1,144
| -12% | -$59.4K |
|
157
Vanguard Dividend Appreciation ETF
VIG
$95.1B
| $456K | 0.08% |
3,376
| – | – |
|
158
American Tower
AMT
$91.9B
| $454K | 0.08% |
2,114
+17
| +0.8% | +$3.65K |
|
159
Roper Technologies
ROP
$56.4B
| $450K | 0.08% |
1,250
-12
| -1% | -$4.32K |
|
160
Vanguard ESG US Stock ETF
ESGV
$11.1B
| $446K | 0.08% |
7,087
+5,107
| +258% | +$321K |
|
161
PayPal
PYPL
$66.5B
| $446K | 0.08% |
5,185
+351
| +7% | +$30.2K |
|
162
Applied Materials
AMAT
$124B
| $442K | 0.07% |
5,394
+1,014
| +23% | +$83.1K |
|
163
Novartis
NVS
$248B
| $437K | 0.07% |
5,753
+56
| +1% | +$4.25K |
|
164
Cincinnati Financial
CINF
$24B
| $434K | 0.07% |
4,840
+359
| +8% | +$32.2K |
|
165
Amgen
AMGN
$153B
| $431K | 0.07% |
1,911
+962
| +101% | +$217K |
|
166
Netflix
NFLX
$521B
| $424K | 0.07% |
1,799
-175
| -9% | -$41.2K |
|
167
Hershey
HSY
$37.4B
| $423K | 0.07% |
1,919
+66
| +4% | +$14.5K |
|
168
Qualcomm
QCOM
$170B
| $422K | 0.07% |
3,731
-231
| -6% | -$26.1K |
|
|
HZNP
169
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $417K | 0.07% |
6,743
-58
| -0.9% | -$3.59K |
|
170
KLA
KLAC
$111B
| $413K | 0.07% |
1,365
-4
| -0.3% | -$1.21K |
|
171
Technology Select Sector SPDR Fund
XLK
$83.6B
| $413K | 0.07% |
3,480
-321
| -8% | -$38.1K |
|
172
Berkshire Hathaway Class A
BRK.A
$1.08T
| $406K | 0.07% |
+1
| New | +$406K |
|
173
Fiserv
FI
$74.3B
| $406K | 0.07% |
4,336
+165
| +4% | +$15.5K |
|
174
Illinois Tool Works
ITW
$76.2B
| $400K | 0.07% |
2,212
+135
| +6% | +$24.4K |
|
175
MetLife
MET
$53.6B
| $388K | 0.07% |
6,391
-865
| -12% | -$52.5K |
|